Terms ending in 2029
Every in-force patent on Antares Pharma, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,867,949 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 10,709,844 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 11,684,723 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 12,623,027 | Injector Safety Device In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 8,376,993 | Multiple Dosage Injector In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 8,915,889 | Multiple Dosage Injector In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 9,561,333 | Multiple Dosage Injector In force · High confidence | Antares Pharma, Inc. | In force | High confidence | |
| US 10,300,212 | Multiple Dosage Injector In force · High confidence | Antares Pharma, Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.